Autoimmune disease Clinical Trials
Recruiting autoimmune disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat autoimmune disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting autoimmune disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting autoimmune disease trials
ACT for Veterans With IBD and Mental Health Challenges
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
Exercise With and Without Cognitive Training
Apremilast and Adalimumab in Psoriatic Arthritis Patients
Lead Exposure and Multiple Sclerosis
Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis
Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care
Ex Vivo Study of hAMSC Secretome in Inflammatory Bowel Disease: Effects on Inflammation and Fibrosis (TARGET)
A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus
Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)
A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
Saphnelo Use in Females of Child-bearing Potential
Cognitive Musical Screening and Therapeutic Innovation in Multiple Sclerosis
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
Safety and Efficacy of ONT01 in Lupus
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project
Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis
My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis
Nailfold Capillaroscopic Changes in Psoriasis
Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Emerging Indications for Hyperbaric Oxygen Treatment
The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health
Opzelura Experience Study
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Online Pain Education for Crohn's Disease and Ulcerative Colitis
Inspiratory Muscle Training in Individuals With Multiple Sclerosis
Efficacy and Tolerability of a Probiotic Ointment
Personalized Approach to Celiac Disease Diagnosis
FES: Effect on Walking in the Real World and Participation in Daily Life in People With Multiple Sclerosis.
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis
Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis
Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
Microbiome-targeted Diet Therapy in Ulcerative Colitis
Retrospective Observational Multicenter Study on the Treatment Patterns, Extra-Intestinal Manifestations, Resource Utilisation, and Outcomes of Patients With Inflammatory Bowel Disease in Dutch Hospitals
Azithromycin in Atopic Dermatitis
US Zamto-cel Autoimmune Diseases
Assessing Psoriasis Treatment Outcomes
A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
An Online Nurse-Led Purpose-Focused Group Program for Adult Women With Multiple Sclerosis: Effects on Meaning and Quality of Life
The Effects of High-Intensity Interval Training on Gait, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
A Clinical Study of HRS-8797 in Healthy Participants
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
Autoimmune disease clinical trials — common questions
Are autoimmune disease clinical trials free to join?
Yes. Participating in a autoimmune disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a autoimmune disease clinical trial?
Each autoimmune disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a autoimmune disease trial near me?
Use the location controls above. We'll show recruiting autoimmune disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many autoimmune disease trials are recruiting right now?
We're currently tracking roughly 663 recruiting autoimmune disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.